Pretax income is the income that a company earns before paying income taxes. bluebird bio's pretax income for the
three
months ended in Sep. 2024 was $-60.87 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Sep. 2024 was $-292.91 Mil.
bluebird bio's pretax margin was -573.56%.
During the past 13 years, bluebird bio's highest Pretax Margin was -238.02%. The lowest was -15357.18%. And the median was -1100.94%.
bluebird bio Pre-Tax Income Historical Data
The historical data trend for bluebird bio's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of bluebird bio's Pre-Tax Income
For the Biotechnology subindustry, bluebird bio's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
bluebird bio's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, bluebird bio's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where bluebird bio's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-292.91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
bluebird bio (NAS:BLUE) Pre-Tax Income Explanation
bluebird bio's Pretax Margin for the quarter that ended in Sep. 2024 is calculated as
During the past 13 years, bluebird bio's highest Pretax Margin was -238.02%. The lowest was -15357.18%. And the median was -1100.94%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
bluebird bio Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of bluebird bio's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BLUE has been successfully added to your 